Thoracic Catheters Market

Thoracic Catheters Market Research Report By Type of Catheter (Percutaneous Central Venous Catheter, Non-tunneled CVC, Tunneled CVC, Implanted CVC, Peripherally Inserted Central Catheter), By Material (Polyurethane, Silicone, Chlorinated polyvinyl chloride), By Application (Hemodialysis, Infusion, Drug delivery, Monitoring), By End User (Hospitals, Clinics, Ambulatory Surgery Centers), By Size (4 French, 5 French, 6 French, 7 French, 8 French, 9 French, 10 French) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035
ID: MRFR/MED/26214-HCR 100 Pages Rahul Gotadki Last Updated: September 17, 2026
Thoracic Catheters Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)3.72%
2024 Market Size$ 3.48 Billion
2025 Market Size$ 3.61 Billion
2035 Market Size$ 5.2 Billion
Key Players
Medtronic
Boston Scientific
Teleflex
B. Braun Melsungen AG
Smiths Medical
Halyard Health
Trends
  • Technological Advancements
  • Patient-Centric Approaches
  • Emerging Market Growth
Opportunities
  • Regulatory Support and Standardization
  • Patient-Centric Approaches in Healthcare
  • Rising Incidence of Respiratory Disorders
Request Free Sample

Thoracic Catheters Market Summary

As per Market Research Future analysis, the Thoracic Catheters Market Size was estimated at 3.482 USD Billion in 2024. The Thoracic Catheters industry is projected to grow from 3.611 USD Billion in 2025 to 5.204 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 3.72% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Thoracic Catheters Market is experiencing robust growth driven by technological advancements and increasing healthcare demands.

  • North America remains the largest market for thoracic catheters, driven by advanced healthcare infrastructure and high demand.
  • The Asia-Pacific region is emerging as the fastest-growing market, fueled by increasing investments in healthcare and rising patient populations.
  • Tunneled central venous catheters (CVC) dominate the market, while peripherally inserted central catheters are witnessing the fastest growth due to their ease of use.
  • Technological advancements and rising incidence of respiratory disorders are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 3.482 (USD Billion)
2035 Market Size 5.204 (USD Billion)
CAGR (2025 - 2035) 3.72%

Major Players

Medtronic (US), Boston Scientific (US), Teleflex (US), B. Braun Melsungen AG (DE), Smiths Medical (US), Halyard Health (US), Cook Medical (US), ConvaTec (GB), Cardinal Health (US)

Thoracic Catheters Market Drivers

Regulatory Support and Standardization

Regulatory support and standardization are playing a pivotal role in shaping the Thoracic Catheters Market. Governments and regulatory bodies are implementing guidelines that promote the safe and effective use of thoracic catheters. This regulatory framework not only ensures patient safety but also encourages manufacturers to innovate and improve their products. The establishment of standardized protocols for thoracic procedures is likely to enhance the overall quality of care, further driving market growth. As healthcare providers adhere to these regulations, the demand for compliant and high-quality thoracic catheters is expected to rise, contributing to the market's expansion.

Patient-Centric Approaches in Healthcare

The shift towards patient-centric approaches in healthcare is influencing the Thoracic Catheters Market significantly. Healthcare providers are increasingly focusing on personalized treatment plans that cater to individual patient needs. This trend is fostering the development of thoracic catheters that are designed with enhanced comfort and usability in mind. As patients become more involved in their treatment decisions, the demand for innovative and user-friendly thoracic catheters is likely to rise. Furthermore, the emphasis on improving patient experiences and outcomes is expected to drive market growth, as providers seek to implement solutions that align with these evolving expectations.

Rising Incidence of Respiratory Disorders

The increasing prevalence of respiratory disorders is a significant driver for the Thoracic Catheters Market. Conditions such as chronic obstructive pulmonary disease (COPD) and pneumonia are on the rise, necessitating the use of thoracic catheters for effective management. According to recent data, respiratory diseases account for a substantial percentage of global morbidity and mortality, leading to a heightened demand for thoracic interventions. This trend is expected to propel the market forward, as healthcare providers seek advanced solutions to address these challenges. The growing awareness of respiratory health is likely to further stimulate the adoption of thoracic catheters in clinical settings.

Technological Advancements in Thoracic Catheters

The Thoracic Catheters Market is experiencing a notable transformation due to rapid technological advancements. Innovations such as the development of minimally invasive catheters and smart catheters equipped with sensors are enhancing patient outcomes. These advancements not only improve the accuracy of procedures but also reduce recovery times. The integration of imaging technologies with thoracic catheters is also gaining traction, allowing for real-time monitoring during procedures. As a result, the market is projected to grow at a compound annual growth rate of approximately 6.5% over the next few years, driven by the demand for more efficient and effective thoracic interventions.

Emerging Markets and Healthcare Infrastructure Development

The expansion of healthcare infrastructure in emerging markets is a crucial driver for the Thoracic Catheters Market. As countries invest in improving their healthcare systems, the demand for advanced medical devices, including thoracic catheters, is increasing. This growth is particularly evident in regions where access to healthcare is improving, leading to a rise in thoracic procedures. The market is likely to benefit from government initiatives aimed at enhancing healthcare access and affordability. As a result, the Thoracic Catheters Market is expected to witness substantial growth in these regions, driven by the increasing availability of healthcare services.

Market Segment Insights

By Type: Tunneled CVC (Largest) vs. Peripherally Inserted Central Catheter (Fastest-Growing)

The Thoracic Catheters Market is significantly shaped by the distribution of various types of catheters, with Tunneled Central Venous Catheters (CVCs) holding the largest share. This segment's popularity stems from its longer duration of use and lower infection risk compared to other types. Non-tunneled and implanted CVCs also play vital roles, serving specific clinical needs based on duration and placement complexity. However, Peripherally Inserted Central Catheters have emerged as a fast-growing segment, driven by their minimally invasive nature and adaptability in various clinical settings.

Tunneled CVC (Dominant) vs. Peripherally Inserted Central Catheter (Emerging)

Tunneled CVCs are regarded as a dominant player in the Thoracic Catheters Market due to their enhanced functionality and patient comfort over extended periods. They are surgically placed and secured under the skin, making them ideal for long-term therapies such as chemotherapy, total parenteral nutrition, and other chronic conditions. On the other hand, Peripherally Inserted Central Catheters represent an emerging trend, increasingly preferred for their ease of insertion through peripheral veins, primarily in outpatient settings. This segment's rapid growth is influenced by healthcare providers' shift toward minimally invasive procedures and improved patient experiences, providing healthcare professionals with a versatile option for vascular access.

By Material: Polyurethane (Largest) vs. Silicone (Fastest-Growing)

In the Thoracic Catheters Market, the material composition is crucial for performance and patient safety. Currently, polyurethane holds a significant share due to its excellent biocompatibility and mechanical properties, making it the preferred choice for many manufacturers. In addition, chlorinated polyvinyl chloride-based solutions, including pvc catheter variants, continue to support specific thoracic applications where cost efficiency and flexibility are required. Silicone, while trailing in market share, has been gaining traction owing to its flexibility and reduced risk of irritation, positioning it well in the emerging market segments.

Polyurethane (Dominant) vs. Silicone (Emerging)

Polyurethane is the dominant material in the Thoracic Catheters Market primarily because of its superior durability and resistance to kinking under pressure. Its hydrophilic properties enhance comfort and ease of insertion, making it a favored option among healthcare professionals. In contrast, silicone is recognized as an emerging material, valued for its enhanced biocompatibility and softer texture, reducing the likelihood of adverse reactions. Although it occupies a smaller market share currently, its increasing adoption in long-term catheter applications and ongoing innovations are expected to solidify its position in the market.

By Application: Hemodialysis (Largest) vs. Infusion (Fastest-Growing)

In the Thoracic Catheters Market, Hemodialysis represents the largest segment, commanding a significant share due to increasing prevalence of kidney disorders and the rising adoption of renal replacement therapies. Infusion devices are gaining traction, driven by the increasing use of advanced therapies and the demand for efficient drug delivery systems in hospitals and outpatient settings. The market growth for this application segment is primarily fueled by technological advancements leading to more efficient and safer catheter designs. Additionally, an aging population and the increasing incidences of chronic diseases are anticipated to further boost demand. Innovations in infusion pumps and drug delivery mechanisms are expected to drive the infusion segment forward as it becomes the fastest-growing application within the market.

Hemodialysis (Dominant) vs. Infusion (Emerging)

Hemodialysis stands out as the dominant application segment within the Thoracic Catheters Market, primarily due to its essential role in managing patients with chronic kidney diseases. This segment benefits from established protocols and an extensive network of healthcare providers skilled in renal therapies. In contrast, the infusion segment is viewed as emerging, characterized by rapid innovations and a shift towards home-based care, enhancing patient experience and accessibility. Infusion catheters are being integrated with advanced technology such as intelligent pumpsand automated systems, thus improving consistency and reducing complications. Both segments showcase unique characteristics, with Hemodialysis focussing on reliability and efficacy, while Infusion emphasizes technological advancements and adaptability.

By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

In the Thoracic Catheters Market, hospitals represent the largest end-user segment, significantly contributing to overall demand. Their extensive resources, advanced infrastructure, and high patient volume allow hospitals to maintain a dominant share in this market. Clinics, on the other hand, are emerging as a significant player, particularly as they expand their service offerings and cater to an increasing number of outpatient procedures, capturing a notable portion of market share that continues to grow. Growth trends within this segment are driven by technological advancements, an increase in thoracic procedures, and a rising awareness around minimally invasive treatment options. Hospitals are investing in innovative catheter technologies that enhance patient outcomes and operational efficiency. Meanwhile, clinics benefit from a shift in patient preferences towards outpatient care, positioning them as a fast-growing option within the thoracic catheters market.

Hospitals (Dominant) vs. Ambulatory Surgery Centers (Emerging)

Hospitals hold a dominant position in the Thoracic Catheters Market, characterized by their robust capacity for high-volume procedures and specialized care. They are equipped with cutting-edge technologies and skilled personnel, making them the go-to choice for complex thoracic procedures. Conversely, Ambulatory Surgery Centers (ASCs) are emerging as an attractive alternative for patients seeking less invasive treatments. ASCs focus on outpatient procedures, offering a convenient and cost-effective solution for a growing patient demographic. The shift toward outpatient care has allowed ASCs to gain traction, capturing a steadily increasing share of the market, driven by patient preferences for shorter recovery times and lower costs.

By Size: 7 French (Largest) vs. 6 French (Fastest-Growing)

In the Thoracic Catheters Market, the market share distribution reveals a competitive landscape among various sizes. The 7 French size segment currently holds the largest market share, driven by its application in a wide range of clinical scenarios that require reliable drainage solutions. In contrast, the 6 French segment, although smaller in total share, is witnessing rapid adoption due to its emerging use in minimally invasive procedures, reflecting shifting preferences among healthcare providers.

7 French (Dominant) vs. 6 French (Emerging)

The 7 French thoracic catheters are distinguished by their robust design and versatile applicability, making them the dominant choice for healthcare professionals. These catheters offer optimal drainage capabilities in various conditions, ensuring patient safety and comfort. Conversely, the 6 French catheters represent an emerging trend, catering to the growing demand for minimally invasive approaches that reduce recovery times and complications. With advancements in technology and increased focus on patient comfort, the 6 French segment is rapidly gaining traction, appealing to medical facilities looking to enhance their thoracic intervention protocols.

Get more detailed insights about Thoracic Catheters Market
Request Free Sample

Regional Insights

North America : Market Leader in Innovation

North America is the largest market for thoracic catheters, holding approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of respiratory diseases, and a strong focus on innovation in medical devices. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficacy in new product launches. The United States is the primary contributor to this market, with key players such as Medtronic, Boston Scientific, and Teleflex leading the competitive landscape. The presence of established healthcare systems and a high demand for minimally invasive procedures bolster the market. Additionally, ongoing research and development initiatives are expected to enhance product offerings, further solidifying North America's position in the thoracic catheters market.

Europe : Emerging Regulatory Frameworks

Europe is the second-largest market for thoracic catheters, accounting for approximately 30% of the global share. Growth is supported by increasing healthcare expenditure, an aging population, and regulatory frameworks. Companies such as B. Braun Melsungen AG play a vital role, with products including braun tube solutions widely adopted across European healthcare facilities. The European Medicines Agency (EMA) plays a crucial role in overseeing medical device regulations, fostering innovation while maintaining high safety standards.. The competitive landscape is characterized by a mix of established companies and emerging startups focusing on innovative solutions. Collaborative efforts between manufacturers and healthcare providers are enhancing product development, ensuring that the market meets evolving patient needs.

Asia-Pacific : Rapidly Growing Market Potential

Asia-Pacific is witnessing rapid growth in the thoracic catheters market, holding approximately 20% of the global share. The region's expansion is driven by increasing healthcare investments, a growing population, and rising awareness of advanced medical technologies. Countries like China and India are experiencing significant demand for thoracic catheters due to the rising incidence of respiratory diseases and the need for effective treatment options. China is the largest market in the region, supported by government initiatives aimed at improving healthcare access and quality. The competitive landscape features both local and international players, with companies like Cook Medical and Teleflex making significant inroads. The focus on innovation and affordability is expected to drive further growth, making Asia-Pacific a key player in The Thoracic Catheters Market.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region represents a smaller share of the thoracic catheters market, accounting for approximately 5% of the global market. However, it is characterized by untapped opportunities driven by increasing healthcare investments and a growing awareness of advanced medical technologies. The region faces challenges such as varying healthcare infrastructure and regulatory environments, but initiatives to improve healthcare access are underway. Countries like South Africa and the UAE are leading the market, with a growing number of healthcare facilities adopting advanced medical devices. The competitive landscape includes both local manufacturers and international players, with a focus on affordability and accessibility. As healthcare systems evolve, the demand for thoracic catheters is expected to rise, presenting significant growth potential for market players.

Thoracic Catheters Market Regional Image

Key Players and Competitive Insights

Leading Thoracic Catheters Market players are engaged in R activities to introduce new thoracic catheters and expand their product portfolio. Moreover, dominant players are involved in collaborations, partnerships, agreements, and joint ventures to maintain their position and cater to the increasing demand for minimally invasive treatments. These factors are driving a high level of competition in the market, where the major Thoracic Catheters Market players are consistently investing in R to develop novel and technologically advanced products to meet the changing preferences of healthcare professionals and patients.
The competitive landscape is further shaped by large-scale medical device manufacturers whose strategic pipelines, including the becton dickinson pipeline, and financial performance indicators such as icu medical revenue, influence investment patterns and innovation focus. Leading Thoracic Catheters Market player Boston Scientific Corporation offers a wide range of thoracic catheters based on their usage and applications. These include the Arrow Double-Lumen Catheter, Arrow TK2 Temporary Vena Cava Filter, Arrow Cobra PF2 Diagnostic Catheter, and others. The company heavily invests in R&D activities to expand its thoracic intervention offerings and develop new thoracic catheters products. Boston Scientific Corporation is a leading provider of high-quality and cost-effective solutions, which increases its market presence.
Another key player in the Thoracic Catheters Market is Teleflex Incorporated, which offers Arrow Perfusion Cannula, Arrow Flow-Gard Intravascular Filter, Arrow ATC Plus pressure monitoring catheter, and other thoracic catheters. The company is focused on developing high-quality thoracic catheter products to improve the patient’s outcomes. The Teleflex Arrow range of products offers cutting-edge devices that improve end results. The Thoracic Catheters Market profile of the company is enhanced by a solid range of products that address the clinical need.

Key Companies in the Thoracic Catheters Market include

Recent Industry Developments

The Thoracic Catheters Market is expected to reach USD 4.5 billion by 2032, at a CAGR of 3.72% over the forecast period (2024–2032). The market growth is attributed to the rising prevalence of thoracic diseases and increasing demand for minimally invasive procedures. Recent product launches and acquisitions demonstrate growing innovation, while competitive positioning is influenced by broader medical device portfolios, including developments aligned with the becton dickinson pipeline and performance benchmarks such as icu medical revenue trends in critical care devices. News developments in the market include the launch of new products, such as the PleuraFlow Active Pleural Drainage System by Medtronic the PleurX Catheter by Teleflex, and the acquisition of Torax Medical by Smiths Medical.
These developments indicate the growing interest in the thoracic catheters market and the potential for further innovation and growth in the coming years.

Future Outlook

Thoracic Catheters Market Future Outlook

The Thoracic Catheters Market is projected to grow at a 3.72% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of respiratory diseases, and rising healthcare expenditures.

New opportunities lie in:

  • Development of smart thoracic catheters with integrated monitoring systems. Expansion into emerging markets with tailored product offerings. Partnerships with telehealth platforms for remote patient monitoring solutions.

By 2035, the Thoracic Catheters Market is expected to achieve robust growth and enhanced market penetration.

Market Segmentation

Thoracic Catheters Market Size Outlook

  • 4 French
  • 5 French
  • 6 French
  • 7 French
  • 8 French
  • 9 French
  • 10 French

Thoracic Catheters Market Type Outlook

  • Percutaneous Central Venous Catheter
  • Non-tunneled CVC
  • Tunneled CVC
  • Implanted CVC
  • Peripherally Inserted Central Catheter

Thoracic Catheters Market End User Outlook

  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers

Thoracic Catheters Market Material Outlook

  • Polyurethane
  • Silicone
  • Chlorinated polyvinyl chloride

Thoracic Catheters Market Application Outlook

  • Hemodialysis
  • Infusion
  • Drug delivery
  • Monitoring

Report Scope

MARKET SIZE 2024 3.482(USD Billion)
MARKET SIZE 2025 3.611(USD Billion)
MARKET SIZE 2035 5.204(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 3.72% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Medtronic (US), Boston Scientific (US), Teleflex (US), B. Braun Melsungen AG (DE), Smiths Medical (US), Halyard Health (US), Cook Medical (US), ConvaTec (GB), Cardinal Health (US)
Segments Covered Type of Catheter, Material, Application, End User, Size, Regional
Key Market Opportunities Advancements in minimally invasive techniques enhance growth potential in the Thoracic Catheters Market.
Key Market Dynamics Rising demand for minimally invasive procedures drives innovation and competition in the thoracic catheters market.
Countries Covered North America, Europe, APAC, South America, MEA

Frequently Asked Questions

What is the projected market valuation of the Thoracic Catheters Market by 2035?

The Thoracic Catheters Market is projected to reach a valuation of 5.204 USD Billion by 2035.

What was the market valuation of the Thoracic Catheters Market in 2024?

In 2024, the Thoracic Catheters Market was valued at 3.482 USD Billion.

What is the expected CAGR for the Thoracic Catheters Market during the forecast period 2025 - 2035?

The expected CAGR for the Thoracic Catheters Market during the forecast period 2025 - 2035 is 3.72%.

Which companies are considered key players in the Thoracic Catheters Market?

Key players in the Thoracic Catheters Market include Medtronic, Boston Scientific, Teleflex, and B. Braun Melsungen AG.

What are the projected valuations for different types of thoracic catheters by 2035?

By 2035, projected valuations for types of thoracic catheters include 1.2 USD Billion for Percutaneous Central Venous Catheters and 0.9 USD Billion for Non-tunneled CVC.

How does the material used in thoracic catheters impact market valuation?

The market valuation for materials such as Polyurethane and Silicone is projected to reach 1.8 USD Billion and 1.5 USD Billion, respectively, by 2035.

What applications are driving growth in the Thoracic Catheters Market?

Applications such as Infusion and Drug delivery are expected to drive growth, with projected valuations of 1.5 USD Billion and 1.2 USD Billion by 2035.

Which end-user segments are anticipated to contribute significantly to the market?

Hospitals are projected to contribute significantly, with a valuation of 2.2 USD Billion by 2035, followed by Ambulatory Surgery Centers at 1.7 USD Billion.

What size categories are available in the Thoracic Catheters Market, and what are their projected valuations?

Size categories such as 8 French and 7 French are projected to reach valuations of 1.2 USD Billion and 1.0 USD Billion, respectively, by 2035.

How does the competitive landscape of the Thoracic Catheters Market appear?

The competitive landscape appears robust, with companies like Smiths Medical and Halyard Health actively participating in the market.

Author
Author Author Profile Rahul Gotadki LinkedIn Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch

Research Approach

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, clinical publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health (CDRH), European Medicines Agency (EMA) Medical Device Coordination Group (MDCG), International Organization for Standardization (ISO) Technical Committee 84 (Devices for use in injection, cannulation, and infusion), Society for Vascular Surgery (SVS), American College of Chest Physicians (CHEST), American Thoracic Society (ATS), Society of Interventional Radiology (SIR), National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI), National Center for Biotechnology Information (NCBI/PubMed), Centers for Disease Control and Prevention (CDC) National Center for Health Statistics, World Health Organization (WHO) Global Health Observatory, Centers for Medicare & Medicaid Services (CMS) Procedure Data, EU Eurostat Health Database, National Kidney Foundation (NKF) dialysis statistics, and national health ministry reports from key markets. These sources were used to collect procedure statistics for hemodialysis catheterization, thoracic drainage procedures, central venous access data, regulatory approval data for Class II and III medical devices, clinical safety studies on catheter-related bloodstream infections (CRBSI), demographic trends in chronic kidney disease and respiratory disorders, and market landscape analysis for polyurethane, silicone, and chlorinated polyvinyl chloride catheter technologies.

Primary Research

In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, VPs of Product Development, heads of regulatory affairs, and commercial directors from suppliers of polymer materials, medical device makers, and thoracic catheter manufacturers were examples of supply-side sources. Interventional radiologists, thoracic surgeons, vascular surgeons, medical directors of dialysis centers, critical care physicians, and procurement leads from hospitals, ambulatory surgery centers, and specialty clinics that perform thoracic drainage and central line insertions were demand-side sources. Primary research verified product pipeline timelines for antimicrobial-coated and power-injectable catheters, validated market segmentation across catheter types (tunneled CVCs, non-tunneled CVCs, PICCs, implanted ports), and collected data on clinical adoption patterns, ASP trends by French size, reimbursement dynamics under Medicare's ESRD bundled payment system, and infection prevention protocols influencing device selection.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)

By Region: North America (38%), Europe (25%), Asia-Pacific (28%), Rest of World (9%)

Market Size Estimation

Global market valuation was derived through revenue mapping and procedure volume analysis. The methodology included:

Identification of 40+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America specializing in central venous access devices and thoracic drainage systems

Product mapping across polyurethane catheters, silicone catheters, chlorinated polyvinyl chloride (cPVC) catheters, and antimicrobial-coated variants

Segment analysis by catheter type (percutaneous central venous catheters, tunneled CVCs, non-tunneled CVCs, implanted CVCs, peripherally inserted central catheters), French sizes (4Fr-10Fr), and applications (hemodialysis, infusion therapy, drug delivery, hemodynamic monitoring)

Analysis of reported and modeled annual revenues specific to thoracic catheter and central venous access device portfolios

Coverage of manufacturers representing 75-80% of global market share in 2024

Extrapolation using bottom-up (procedure volume × ASP by country for hemodialysis catheter insertions, PICC placements, and thoracic drainage procedures) and top-down (manufacturer revenue validation against public filings and segment disclosures) approaches to derive segment-specific valuations for hospital, clinic, and ambulatory surgery center end-users

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.